CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net revenue	$ 744,626	$ 706,203
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	$ 655,396	$ 597,122
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 47,521	$ 41,444
Depreciation and amortization, excluding patient equipment depreciation	15,532	16,085
Total costs and expenses	718,449	654,651
Operating income	26,177	51,552
Interest expense, net	31,955	24,776
Change in fair value of warrant liability (note 10)	(21,914)	(26,717)
Other loss, net	1,175	5,660
Income before income taxes	14,961	47,833
Income tax (benefit) expense	(1,714)	5,603
Net income	16,675	42,230
Income attributable to noncontrolling interest	968	480
Net income attributable to AdaptHealth Corp.	$ 15,707	$ 41,750
Weighted average common shares outstanding - basic (in shares)	134,525	134,023
Weighted average common shares outstanding - diluted (in shares)	135,976	138,483
Basic net income per share (note 11) (in dollars per share)	$ 0.11	$ 0.29
Diluted net (loss) income per share (note 11) (in dollars per share)	$ (0.06)	$ 0.08